Real-time enrollment status for this solid tumor clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:45 PM UTC
| NCT Number | NCT07095868 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor |
| Phase | Clinical Trial |
| Target Enrollment | 94 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Everest Medicines (Beijing) Co., Ltd. |
| Last Updated on CT.gov | May 27, 2026 (May 27, 2026) |
As of July 13, 2026: Clinical trial NCT07095868 is currently recruiting participants. This clinical trial study for solid tumor is actively seeking new participants at 3 locations across the United States. The study is sponsored by Everest Medicines (Beijing) Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07095868 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07095868 was last updated May 27, 2026 (May 27, 2026). HelloStudys verifies this status automatically.